Calendar · pharmadog

Sign In Subscribe

Date TBD

50

NOT_YET_RECRUITINGphase readoutNCT07428018: Pragmatic Study to Optimize Neoadjuvant Treatment and Surgical De-escalation in HR+/HER2- Early Breast Cancer Using Oncotype DX and Abemaciclib

Sponsor: Mario Negri Institute for Pharmacological Research. Phase: PHASE2. Conditions: Breast Cancer, HER2 + Breast Cancer, HR Positive, Neoadjuvant Therapy

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT07579390: Effects of Sedation, TEmperature and Pressure After Cardiac Arrest and REsuscitation on Major Adverse Kidney Events (STEPCARE-MAKE)

Sponsor: Helsinki University Central Hospital. Phase: NA. Conditions: Acute Kidney Failure, Renal Replacement Therapy for Acute Kidney Injury in ICU, Sedation in Intensive Care Unit Patients, Sedation in the ICU, Sedation in Intensive Care, Blood Pressure, Mean Arterial Pressure Targets, Temperature, Fever, Resuscitated Sudden Cardiac Death, Out of Hospital Cardiac Arrest, Cardiac Arrest (CA)

full page →ctgov ↗

RECRUITINGphase readoutNCT07607197: Immunological Reset to Enable Access to Hla-compatible Kidney Transplantation in Highly Sensitized Patients (RESET)

Sponsor: Hospital Universitari Vall d'Hebron Research Institute. Phase: PHASE1. Conditions: Kidney Failure, Chronic, Kidney Transplantation, Alloimmunization, HLA Sensitization, End Stage Cronic Kidney Disease, Highly Sensitized Patients Awaiting Kidney Transplant

full page →ctgov ↗

RECRUITINGphase readoutNCT07222410: Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital

Sponsor: Fisher and Paykel Healthcare. Phase: NA. Conditions: COPD

full page →ctgov ↗

RECRUITINGphase readoutNCT07052513: Modified Autologous Leukocyte Cells for the Treatment of Acute Kidney Injury After Cardiac Surgery

Sponsor: M2RLAB SL. Phase: PHASE2. Conditions: Acute Kidney Injury

full page →ctgov ↗

COMPLETEDphase readoutNCT07330713: Platelet-Rich Plasma for Acute Nonarteritic Anterior Ischemic Optic Neuropathy: A Prospective Randomized Controlled Study

Sponsor: Uludag University. Phase: NA. Conditions: Nonarteritic Anterior Ischemic Optic Neuropathy

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT02462460: Rapid Pancreatic and Ovarian Screening MR Imaging With Motion Corrected T1, T2, and Advanced Diffusion Weighted Imaging for Patients With BRCA Mutation Who Undergo Screening Breast MRI

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: . Conditions: Screening Breast MRI in Patients Who Are BRCA Mutation Carriers

full page →ctgov ↗

RECRUITINGphase readoutNCT07585760: CM336 Plus Isatuximab for Newly Diagnosed Multiple Myeloma With Renal Impairment

Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: PHASE2. Conditions: Multiple Myeloma (MM), Multiple Myeloma Light Chain Induced Renal Insufficiency

full page →ctgov ↗

COMPLETEDphase readoutNCT07729020: Effectiveness of Virtual Reality in Reducing Anxiety and Pain During the First Postoperative Orthopedic Dressing Change in Pediatric Patients

Sponsor: Gianluca Catania. Phase: NA. Conditions: Anxiety, Pain, Post Operative

full page →ctgov ↗

COMPLETEDphase readoutNCT07471620: The Effect of High Intensity Functional Exercise Programs on Menopausal Symptoms, Physical Performance, and Dual Task Performance in Postmenopausal Women

Sponsor: Uskudar University. Phase: NA. Conditions: Postmenopausal Period

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07528820: Inflammatory Profiles, Histopathological Features, and Remodeling Factors in Chronic Rhinosinusitis With Nasal Polyps

Sponsor: St. Paul's Sinus Centre. Phase: NA. Conditions: CRSwNP, Chronic Rhinosinusitis (Diagnosis), Nasal Polyposis

full page →ctgov ↗

COMPLETEDphase readoutNCT04142320: Closed-loop Optimized rTMS for Depression

Sponsor: Stanford University. Phase: PHASE1. Conditions: Major Depressive Disorder

full page →ctgov ↗

RECRUITINGphase readoutNCT07372820: METABolic Deterioration in HTX Determines Outcomes

Sponsor: Heinrich-Heine University, Duesseldorf. Phase: . Conditions: Heart Transplantation

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07362524: AI-Assisted Real-Time Endoscopic Characterization of Diminutive Colorectal Polyps in Non-Academic Hospitals

Sponsor: Shanghai Jiao Tong University School of Medicine. Phase: NA. Conditions: Colorectal Polyps

full page →ctgov ↗

RECRUITINGphase readoutNCT06912724: Pediatric Neuroimaging

Sponsor: National Institute on Aging (NIA). Phase: . Conditions: Neurogimaging

full page →ctgov ↗

COMPLETEDphase readoutNCT05987696: Natural Killer(NK) Cell Therapy in Acute Myeloid Leukemia

Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: PHASE1. Conditions: AML, Adult, Minimal Residual Disease

full page →ctgov ↗

COMPLETEDphase readoutNCT04301596: Assessment of Nutritional Status in Systemic Sclerosis

Sponsor: University Hospital, Montpellier. Phase: . Conditions: Systemic Sclerosis

full page →ctgov ↗

RECRUITINGphase readoutNCT06840496: To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome

Sponsor: Biomed Industries, Inc.. Phase: PHASE3. Conditions: Rett Syndrome

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07228962: Cutaneous Biomarkers in Atopic Eczema Using a Non-Invasive Micro-Suction Device in Babies

Sponsor: King's College London. Phase: . Conditions: Eczema, Atopic Dermatitis, Atopic Eczema

full page →ctgov ↗

COMPLETEDphase readoutNCT06545162: Safety, Tolerability, and Pharmacokinetics of a Single or Multiple Ascending Doses of CPX101

Sponsor: Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Overweight and Obesity

full page →ctgov ↗

RECRUITINGphase readoutNCT06639503: Genicular Nerve Block After Open Reduction Internal Fixation of Tibial Plateau

Sponsor: University of Chicago. Phase: PHASE1. Conditions: Tibial Plateau Fractures

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06384261: A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive Therapy

Sponsor: OncoVerity, Inc.. Phase: PHASE2. Conditions: Leukemia, Myeloid, Acute

full page →ctgov ↗

COMPLETEDphase readoutNCT05497427: Normative Database and Test-Retest Reliability for BrainCheck Assessments

Sponsor: BrainCheck, Inc.. Phase: . Conditions: Cognitive Change, Cognitive Decline, Cognitive Deterioration, Neurocognitive Deficit

full page →ctgov ↗

RECRUITINGphase readoutNCT06687070: APG-2449 Monotherapy or in Combination With PLD in Patients With Platinum-resistant Recurrent OC or Advanced ST

Sponsor: Ascentage Pharma Group Inc.. Phase: PHASE1. Conditions: Platinum-resistant Recurrent Ovarian Cancer, Advanced Solid Tumor

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT04789070: Phase III Trial of Sirolimus in IBM

Sponsor: University of Kansas Medical Center. Phase: PHASE3. Conditions: Inclusion Body Myositis

full page →ctgov ↗

RECRUITINGphase readoutNCT04302870: Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised Trial

Sponsor: University of Edinburgh. Phase: PHASE2. Conditions: Motor Neuron Disease, Amyotrophic Lateral Sclerosis

full page →ctgov ↗

RECRUITINGphase readoutNCT05796570: A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies

Sponsor: Franziska Wachter. Phase: PHASE2. Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes, Myeloid Malignancies, MDS, Inherited Bone Marrow Failure Syndrome, Myeloid Neoplasm, Aml

full page →ctgov ↗

TERMINATEDphase readoutNCT04869670: A Study to Evaluate Safety and Effectiveness of G-POEM for Gastroparesis

Sponsor: Mayo Clinic. Phase: NA. Conditions: Gastroparesis

full page →ctgov ↗

COMPLETEDphase readoutNCT05756270: Clinical Applicability of pCASL as a Substitute for FDG-PET in MCI and SCD Patients

Sponsor: University of Milano Bicocca. Phase: . Conditions: Mild Cognitive Impairment, Subjective Cognitive Decline

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07445373: Role of the WHO Labour Care Guide in Improving Maternal and Fetal Outcomes

Sponsor: Khyber Teaching Hospital. Phase: NA. Conditions: Labor and Delivery

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06651073: ATTR-CM: A Multi-country, Non-interventional Disease Registry

Sponsor: Pfizer. Phase: . Conditions: Transthyretin Amyloid Cardiopathy

full page →ctgov ↗

COMPLETEDphase readoutNCT06870669: The Effect of Progressive Relaxation Exercises by Nursing Students Before Clinical Practice

Sponsor: Manisa Celal Bayar University. Phase: NA. Conditions: Healthy, Stress, Exercise

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07663773: Thyroid Hormones in CKD

Sponsor: Mario Negri Institute for Pharmacological Research. Phase: . Conditions: Chronic Kidney Disease (Stages 4 and 5)

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT07233655: A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid Arthritis

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd. Phase: PHASE2. Conditions: Moderate to Severe Active Rheumatoid Arthritis

full page →ctgov ↗

RECRUITINGphase readoutNCT07243626: Efficacy and Safety of Envafolimab Plus Doxorubicin and Ifosfamide for Advanced Soft Tissue Sarcoma

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University. Phase: PHASE2. Conditions: Soft Tissue Sarcoma

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07430826: Building Opportunities for Nurturing Care to Enhance Child Development in Eastern and Southern Africa

Sponsor: University of Washington. Phase: NA. Conditions: Neurodevelopment, Child Growth

full page →ctgov ↗

RECRUITINGphase readoutNCT03448926: The PREDICT Registry:

Sponsor: PreludeDx. Phase: . Conditions: DCIS, Stage 0 Breast Cancer, Ductal Breast Carcinoma In Situ

full page →ctgov ↗

RECRUITINGphase readoutNCT07224178: Left Atrial Strain and Cryptogenic Stroke

Sponsor: University of Pittsburgh. Phase: . Conditions: Ischemic Stroke, Cryptogenic, Ischemic Stroke, Embolic, Hemorrhagic Stroke, Embolic Stroke of Undetermined Source, Recurrent Ischemic Stroke

full page →ctgov ↗

RECRUITINGphase readoutNCT07489378: NCI Childhood Cancer Data Initiative (CCDI) Led Pediatric, Adolescent, and Young Adult Rare Cancer Registry for Very Rare Solid Tumors

Sponsor: National Cancer Institute (NCI). Phase: . Conditions: Very Rare Tumors, Very Rare Cancers, Other Solid Tumors, Solid Tumor, Pediatric Rare Tumors

full page →ctgov ↗

COMPLETEDphase readoutNCT03123978: Enzalutamide and Niclosamide in Treating Patients With Recurrent or Metastatic Castration-Resistant Prostate Cancer

Sponsor: University of California, Davis. Phase: PHASE1. Conditions: Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer

full page →ctgov ↗

COMPLETEDphase readoutNCT07586748: Pressure Ulcer Development Device Related

Sponsor: Assuta Medical Center. Phase: . Conditions: Pressure Ulcer, Pressure Ulcer Prevention, Venous Thrombosis Deep (Limbs)

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT07703748: Long-Term Real-World Evidence Study to Evaluate Effectiveness, Persistence, Adherence, Safety and Tolerability of Long-acting Cabotegravir Plus Rilpivirine.

Sponsor: FUNDACIÓN HOSPITAL UNIVERSITARIO INFANTA LEONOR Y DEL HOSPITAL UNIVERSITARIO DEL SURESTE. Phase: . Conditions: Human Immunodeficiency Virus Infection (HIV), HIV-1 Infection in Adults

full page →ctgov ↗

COMPLETEDphase readoutNCT07331948: INFLUENCE OF VOJTA THERAPY IN CEREBRAL PALSY. INFANTILE HEMIPARESIS

Sponsor: Centro Integral Kaplan. Phase: NA. Conditions: Pediatric Hemiparesis

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07319455: Heart Voice: Starry Journey - A Digital ACT Intervention for ASD Caregivers

Sponsor: Harbin Medical University. Phase: NA. Conditions: Autism Spectrum Disorder

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07490626: At-Home Paracentesis for Women With Cancer-Related Malignant Ascites (Paracentesis)

Sponsor: University of Utah. Phase: NA. Conditions: Malignant Ascites

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT03069378: A Study of Talimogene Laherparepvec (T-VEC) in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Sarcoma, Epithelioid Sarcoma, Cutaneous Angiosarcoma

full page →ctgov ↗

WITHDRAWNphase readoutNCT07251985: Cognitive Effects of Bioavailable Curcumin

Sponsor: University of California, Los Angeles. Phase: PHASE2. Conditions: Memory, Cognitive Function Decline

full page →ctgov ↗

COMPLETEDphase readoutNCT07398885: Assessing the Impact of Herbal Supplement on Fatigue and Disease Activity in SLE: Results From an 8-Week Randomized Trial

Sponsor: University Tunis El Manar. Phase: NA. Conditions: System; Lupus Erythematosus

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07709585: Befotertinib Plus Chemotherapy With an MRD-guided Adaptive Strategy for Treatment Escalation and Response Optimization in EGFR-mutated NSCLC Patients

Sponsor: Guangzhou University of Traditional Chinese Medicine. Phase: PHASE2. Conditions: Advanced Non-small Cell Lung Cancer (NSCLC), EGFR Exon 19 Deletion Mutation, EGFR Exon 21 Mutation, EGFR Exon 21 L858R Mutation

full page →ctgov ↗

RECRUITINGphase readoutNCT03391778: Adoptive Cell Therapy Long-term Follow-up (LTFU) Study

Sponsor: USWM CT, LLC. Phase: PHASE1. Conditions: Neoplasms

full page →ctgov ↗